biote Corp.
BTMD Healthcare Medical Care Facilities
biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024.
- Revenue
- −9.48%
- EPS
- −330.0%
- Free cash flow
- −174.2%
- Total debt
- +16.0%
Quarter to June 2026, against a year earlier
Follow BTMD
Alert me
biote Corp. (BTMD) P/E ratio
As of 6 November 2026, biote Corp. (BTMD) trades at a P/E ratio of 6.6×. Over the past ten years it has ranged from 0.0× (March 2024) to 70.4× (June 2024); the current reading is higher than 72% of that period. That is below the Medical Care Facilities industry median of 18.7× and below the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 3.0× | (92.66%) |
| FY2024 | 41.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.3× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 11.8× | 328.75% |
| Mar 2026 | 2.8× | (8.87%) |
| Dec 2025 | 3.0× | (7.29%) |
| Sep 2025 | 3.3× | (18.88%) |
| 17 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| DCGO DocGo Inc. compare | n/m |
| PARK Park Dental Partners, Inc. compare | n/m |
| CCM Concord Medical Services Holdings Limited compare | n/m |
| AIRS AirSculpt Technologies, Inc. compare | n/m |
| PIII P3 Health Partners Inc. compare | n/m |
| CCEL Cryo-Cell International Inc. compare | n/m |
| BTMD biote Corp. | 6.6× |
| JYNT The Joint Corp. compare | 25.5× |
| BMGL Basel Medical Group Ltd compare | — |
| Medical Care Facilities industry median | 18.7× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)